These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20383858)

  • 1. Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill?
    Kleger GR; Fässler E
    Int J Artif Organs; 2010 Mar; 33(3):139-46. PubMed ID: 20383858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Renal Replacement Therapy in Venovenous Extracorporeal Membrane Oxygenation: A Retrospective Study on Regional Citrate Anticoagulation.
    Giani M; Scaravilli V; Stefanini F; Valsecchi G; Rona R; Grasselli G; Bellani G; Pesenti AM; Foti G
    ASAIO J; 2020 Mar; 66(3):332-338. PubMed ID: 31045918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
    Nagarik AP; Soni SS; Adikey GK; Raman A
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration.
    Park JS; Kim GH; Kang CM; Lee CH
    Korean J Intern Med; 2011 Mar; 26(1):68-75. PubMed ID: 21437165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous venovenous renal replacement therapy in critically ill patients: A work load analysis.
    Houllé-Veyssière M; Courtin A; Zeroual N; Gaudard P; Colson PH
    Intensive Crit Care Nurs; 2016 Oct; 36():35-41. PubMed ID: 27283118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of circuit patency and exchange rates between 2 different continuous renal replacement therapy machines.
    Razavi SA; Still MD; White SJ; Buchman TG; Connor MJ
    J Crit Care; 2014 Apr; 29(2):272-7. PubMed ID: 24360820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
    Davies H; Morgan D; Leslie G
    Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.
    Tolwani AJ; Prendergast MB; Speer RR; Stofan BS; Wille KM
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):79-87. PubMed ID: 17699194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.
    Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D
    Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circuit life span of continuous renal replacement therapy in critically ill patients with or without conventional anticoa-gulation: an observational prospective study].
    Sanz M; Hidalgo F; García-Fernández N
    An Sist Sanit Navar; 2017 Apr; 40(1):77-84. PubMed ID: 28534557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
    Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.
    Klingele M; Stadler T; Fliser D; Speer T; Groesdonk HV; Raddatz A
    Crit Care; 2017 Nov; 21(1):294. PubMed ID: 29187232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.